March 2021 EGRP Cancer Epidemiology News

EGRP Cancer Epidemiology News


New Guidance Documents for Researchers Conducting Studies on Immune Response to COVID-19 Vaccines

The National Cancer Institute’s (NCI) Serological Sciences Network (SeroNet) is the nation’s largest coordinated effort to study the immune response to COVID-19. The network was established “to develop, validate, improve, and implement serological testing and associated technologies.”

SeroNet investigators have created guidance documents for researchers conducting studies on the immune response to vaccines to encourage harmonization across studies and to allow for cross-study comparisons. The available documents include study design templates, standard operating procedures, and common data elements.

SeroNet is led by NCI, in close collaboration with the National Institute of Allergy and Infectious Diseases and involves 25 of the nation’s top biomedical research institutions. More information about SeroNet is available on NCI’s website.

Funding Opportunity Announcements

  • Maximizing the Scientific Value of Existing Biospecimen Collections (R21, Clinical Trial Not Allowed)
  • Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21, Clinical Trial Not Allowed)
  • Modular R01s in Cancer Control and Population Sciences (R01, Clinical Trial Optional)
  • Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03, Clinical Trial Not Allowed)
  • Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01, R21, Clinical Trial Optional)
  • Notice of Special Interest (NOSI): Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health (NOT-HD-20-032)
  • NOSI: Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data (NOT-CA-21-049)
  • NOSI: Administrative Supplements for Research on Womens Health in the IDeA States (NOT-GM-21-018)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Research Grants for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-Associated Research (U01, Clinical Trial Optional)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-Associated Research (U01, Clinical Trial Not Allowed)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (NOT-MD-21-016)

Requests for Information (RFIs)

  • Inviting Comments and Suggestions to Advance and Strengthen Racial Equity, Diversity, and Inclusion in the Biomedical Research Workforce and Advance Health Disparities and Health Equity Research (NOT-OD-21-066)
  • Leveraging Clinical Trial Populations in NCI’s National Clinical Trial Network (NCTN) and Community Oncology Research Program (NCORP) for Observational Cancer Survivorship Studies (NOT-CA-21-036)
  • Use of Common Data Elements (CDEs) in NIH-funded research (NOT-LM-21-005)

Research Resources

Grants Policy Notices

  • Reminder: NIH Natural Disaster Policy - Winter Storms (NOT-OD-21-067)
  • Upcoming Changes to the Biographical Sketch and Other Support Format Page for Due Dates on or after May 25, 2021 (NOT-OD-21-073)

Job Opportunities

NIH News

NCI Blog Posts

Stay Connected

Subscribe for Updates

Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.

Subscribe to the E-Newsletter

Need Help?

EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.

Email Us
(240) 276-6730